Indeed, in both conditions we observed a population of CD8+ T‐cells enriched for our ISG signature (Figure S2C) with a higher frequency in disease compared with healthy control samples (Figure S2D), suggesting that the ISG cluster phenotype is not restricted to tumor immunity. This evidence concerns the gene CD8A and neoplasm.